SIOUX CITY (KTIV) - Brad Hedlund has been in and out of appointments with cardiologists dealing with heart failure over the last decade. Hedlund explained his symptoms as “I had no energy. I had no ...

(WNDU) - More than 6.5 million Americans are living with heart failure. In the next five years, that number will grow to 8.5 million people. It’s the leading cause of death for men and women. It’s a ...

CLEVELAND, Ohio — The Cleveland Clinic said that it implanted a dual-function cardiac device in a patient as part of a clinical trial this week, marking the first time this has been done in the world.

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

BUFFALO, N.Y. — It is considered groundbreaking technology in Buffalo when it comes to heart health. Cardiac Contractility Modulation Therapy (CCM) is a device that can be implanted in patients. There ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

MINNEAPOLIS -- The novel dual-function cardiac contractility modulation-defibrillator (CCM-D) for heart failure with reduced ejection fraction (HFrEF) had favorable early results in the Integra-D ...

We have moved interventional procedures guidance 655 to become HealthTech guidance 520. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment ...

Please provide your email address to receive an email when new articles are posted on . The Integra-D trial evaluated a novel implantable cardiac contractility modulation defibrillator for its ability ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

The Interventional Procedures Advisory Committee has considered this procedure and NICE has now issued a consultation document about its safety and efficacy. This has been issued for four weeks’ ...